dipyridamole has been researched along with Linear Skull Fracture in 1 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Maliha, SG | 1 |
Lopez, CD | 1 |
Coelho, PG | 1 |
Witek, L | 1 |
Cox, M | 1 |
Meskin, A | 1 |
Rusi, S | 1 |
Torroni, A | 1 |
Cronstein, BN | 1 |
Flores, RL | 1 |
1 other study available for dipyridamole and Linear Skull Fracture
Article | Year |
---|---|
Bone Tissue Engineering in the Growing Calvaria Using Dipyridamole-Coated, Three-Dimensionally-Printed Bioceramic Scaffolds: Construct Optimization and Effects on Cranial Suture Patency.
Topics: Animals; Bone Regeneration; Calcium Phosphates; Dipyridamole; Disease Models, Animal; Rabbits; Skull | 2020 |